QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
Company Information
About this company
Key people
Brian J. Blaser
President, Chief Executive Officer, Director
Joseph M. Busky
Chief Financial Officer
Philip D. Mclellan
Chief Operations Officer
Lee Bowman
Chief Human Resources Officer
Jonathan Siegrist
Executive Vice President - Research and Development, Chief Technology Officer
Michelle A. Hodges
Senior Vice President, Corporate Secretary, Chief Legal Officer
Devon Burek
Senior Vice President - Global Quality
Sergio Gadaleta
Senior Vice President - Clinical and Regulatory Affairs
Kenneth F. Buechler
Independent Chairman of the Board
John R. Chiminski
Independent Director
Evelyn S. Dilsaver
Independent Director
R. Scott Huennekens
Independent Director
Edward L. Michael
Independent Director
Click to see more
Key facts
- Shares in issue67.93m
- EPICQDEL
- ISINUS2197981051
- LocationUnited States
- SectorHealthcare
- IndustryHealthcare Facilities
- Market cap$1.99bn
- Employees6,600
- ExchangeNASDAQ
- IndexS&P 600 Small Cap, TR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.